Diabetes Mellitus, Insulin-Dependent
Item
diagnosed with type 1 diabetes mellitus within 3 months prior to study entry
boolean
C0011854 (UMLS CUI [1])
Anti-insulin autoantibody Positive | Serum Gad65 Auto Antibodies Test Positive | IA-2 antibody Positive | Insulin regime
Item
positive for iaa, gad65, or ia2 antibodies or positive for gad65 or ia2 antibodies after 2 weeks of starting insulin treatment
boolean
C1275890 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C1255118 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
C0528414 (UMLS CUI [3,1])
C1514241 (UMLS CUI [3,2])
C0557978 (UMLS CUI [4])
Oral hypoglycemic
Item
history of treatment with any oral hypoglycemic agent for more than 3 months
boolean
C0359086 (UMLS CUI [1])
Pharmaceutical Preparations Affecting glucose tolerance
Item
ongoing use of medications known to influence glucose tolerance
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0178665 (UMLS CUI [1,3])
Therapeutic immunosuppression | Steroid therapy
Item
history of immunosuppressive or steroid therapy for more than 3 months within the 2 years prior to study entry
boolean
C0021079 (UMLS CUI [1])
C0149783 (UMLS CUI [2])
Liver disease Severe Limiting Life Expectancy | Heart Disease Severe Limiting Life Expectancy | Kidney Disease Severe Limiting Life Expectancy | Immunologic Deficiency Syndrome Severe Limiting Life Expectancy | Liver disease Severe Requirement Therapeutic immunosuppression | Heart Disease Severe Requirement Therapeutic immunosuppression | Kidney Disease Severe Requirement Therapeutic immunosuppression | Immunologic Deficiency Syndrome Severe Requirement Therapeutic immunosuppression
Item
severe active liver, heart, kidney, or immunodeficiency disease that may limit life expectancy or may require immunosuppression during the study
boolean
C0023895 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0023671 (UMLS CUI [1,4])
C0018799 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
C0023671 (UMLS CUI [2,4])
C0022658 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])
C0023671 (UMLS CUI [3,4])
C0021051 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
C0023671 (UMLS CUI [4,4])
C0023895 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C1514873 (UMLS CUI [5,3])
C0021079 (UMLS CUI [5,4])
C0018799 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C1514873 (UMLS CUI [6,3])
C0021079 (UMLS CUI [6,4])
C0022658 (UMLS CUI [7,1])
C0205082 (UMLS CUI [7,2])
C1514873 (UMLS CUI [7,3])
C0021079 (UMLS CUI [7,4])
C0021051 (UMLS CUI [8,1])
C0205082 (UMLS CUI [8,2])
C1514873 (UMLS CUI [8,3])
C0021079 (UMLS CUI [8,4])
Complication of vaccination
Item
prior complications related to routine vaccinations
boolean
C0274430 (UMLS CUI [1])
Study Subject Participation Status | Insulin-Dependent Diabetes Mellitus Prevention
Item
prior participation in a trial for prevention of type 1 diabetes mellitus. individuals who are known to have been in the placebo arm of a completed prevention trial are not excluded.
boolean
C2348568 (UMLS CUI [1])
C0011854 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
Condition Interferes with Protocol Compliance
Item
any condition that may interfere with a participant's ability to comply with the study
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Pregnancy | Pregnancy, Planned
Item
pregnancy or planned pregnancy within the time frame of the study
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])